← 홈

Antibody

163개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 163개
AntibodystaleMedImmune LLCPhase 2

MEDI6469 plus Rituximab (MEDI6469 plus Rituximab)

Advanced Solid Tumors; Aggressive B-cell Lymphomas · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#항체#면역항체+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
AntibodystalePfizerPhase 1

PF-07901801 (Maplirpacept, Maplirpacept (PF-07901801))

Lymphoma; Multiple Myeloma · Lymphoma

#Lymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleNovartisPhase 3

OFATUMUMAB + DHAP (OFATUMUMAB + DHAP)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Phase3#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

G (Obinutuzumab, Obinutuzumab (G))

B-Cell Lymphoma; Non-Hodgkin Lymphoma · B-Cell Lymphoma

#B-CellLymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Obutinib or Decitabine, Rituximab, Compound Cyclophosphamide Tablets and Prednisone (Obutinib or Decitabine, Rituximab, Compound Cyclophosphamide Tablets and Prednisone)

Newly Diagnosed Diffuse Large B-cell Lymphoma · Newly Diagnosed Diffuse Large B-cell Lym

#NewlyDiagnosedDiffuseLargeB-cell#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRegeneron PharmaceuticalsPhase 1

Odronextamab multiple dose levels (Odronextamab multiple dose levels)

Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Orelabrutinib and Rituximab (Orelabrutinib and Rituximab)

Follicular Lymphoma; Relapsed and Refractory Follicular Lymphoma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Pegylated Liposomal Doxorubicin (Doxil, Pegylated Liposomal Doxorubicin, Pegylated Liposomal Doxorubicin (Doxil) and Rituximab)

Non-Hodgkin's Lymphoma; Burkitt Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleMerckPhase 2

ICE or DHAP (Pembrolizumab plus Chemotherapy, Pembrolizumab plus Chemotherapy (ICE or DHAP))

Classical Hodgkin Lymphoma · Classical Hodgkin Lymphoma

#ClassicalHodgkinLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleGerman High-Grade Non-Hodgkin's…Phase 3

R-CHOEP 14 with 12x Rituximab (R-CHOEP 14 with 12x Rituximab)

Non-Hodgkin's Lymphoma (NHL) · Non-Hodgkin's Lymphoma (NHL)

#Non-HodgkinsLymphomaNHL#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChipscreen Biosciences, Ltd.Phase 3

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP, R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone))

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

RITUXIMAB + DHAP (RITUXIMAB + DHAP)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Phase3#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleOslo University HospitalPhase 2

Radiotherapy, rituximab and DC (Radiotherapy, rituximab and DC)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Recombinant Human Interleukin-2 and Rituximab (Recombinant Human Interleukin-2 and Rituximab)

Lymphoma, Non-Hodgkin · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleUniversity of Alabama at Birmin…Phase 1

Retifanlimab, INCAGN02385, INCAGN02390 (Retifanlimab, INCAGN02385, INCAGN02390)

Diffuse Large B Cell Lymphoma; Lymphoma, B-Cell · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#Antibody#Phase1#항체#면역항체+4
효능 ORR 100%임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

where available (Rituximab, Rituximab (where available))

Non-hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Rituximab + MG4101 (Rituximab + MG4101)

CD20-positive Non-Hodgkin Lymphoma · CD20

#CD20#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

Rituximab - Bendamustine (Rituximab - Bendamustine)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Rituximab - CHOP (Rituximab - CHOP)

Diffuse Large B-cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Rituximab - CVP (Rituximab - CVP)

Follicular Lymphoma · Follicular Lymphoma

#FollicularLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE

5 / 9 페이지

← 이전다음 →